|
|
|
|
Evidence on the efficacy of oral antispastic drugs in NPND is weak and does not include evaluation of patientsÆ quality of life. If any, efficacy is marginal. Adverse drug reactions were common. Better methodologic instruments are needed for the evaluation of antispastic treatment. |
|